Lyn A. Glenn

Phase 1 Study of Stereotactic Body Radiotherapy and Interleukin-2—Tumor and Immunological Responses

Steven K. Seung, Brendan D. Curti, Marka R. Crittenden et al. · Science Translational Medicine · 2012 · 305 citations

Medicine, Immunology, Oncology +17

Durable responses and reversible toxicity of high-dose interleukin-2 treatment of melanoma and renal cancer in a Community Hospital Biotherapy Program

Roxanne Payne, Lyn A. Glenn, Helena Hoen et al. · Journal for ImmunoTherapy of Cancer · 2014 · 102 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Survivorship care plans: Is there buy‐in from community oncology providers?

Talya Salz, Mary S. McCabe, Erin E. Onstad et al. · Cancer · 2013 · 69 citations · Full text

Medicine, Oncology, Cancer Survivorship Care +13